Introduction: Minimal residual disease is an important independent prognostic factor that can identify poor responders among patients with acute lymphoblastic leukemia. Objective: The aim of this study was to analyze minimal residual disease using immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements by conventional polymerase chain reaction followed by homo-heteroduplex analysis and to compare this with real-time polymerase chain reaction at the end of the induction period in children with acute lymphoblastic leukemia. Methods: Seventy-four patients diagnosed with acute lymphoblastic leukemia were enrolled. Minimal residual disease was evaluated by qualitative polymerase chain reaction in 57 and by both tests in 44. The Kaplan-Meier and multivariate Cox methods and the log-rank test were used for statistical analysis. Results: Nine patients (15.8%) were positive for minimal residual disease by qualitative polymerase chain reaction and 11 (25%) by real-time polymerase chain reaction considering a cut-off point of 1×10-3 for precursor B-cell acute lymphoblastic leukemia and 1×10-2 for T-cell acute lymphoblastic leukemia. Using the qualitative method, the 3.5-year leukemia-free survival was significantly higher in children negative for minimal residual disease compared to those with positive results (84.1%±5.6% versus 41.7%±17.3%, respectively; p-value=0.004). There was no significant association between leukemia-free survival and minimal residual disease by real-time polymerase chain reaction. Minimal residual disease by qualitative polymerase chain reaction was the only variable significantly correlated to leukemia-free survival. Conclusion: Given the difficulties in the implementation of minimal residual disease monitoring by real-time polymerase chain reaction in most treatment centers in Brazil, the qualitative polymerase chain reaction strategy may be a cost-effective alternative. © 2015 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.376373380van der Velden, V.H., Joosten, S.A., Willemse, M.J., van Wering, E.R., Lankester, A.W., van Dongen, J.J., Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia (2001) Leukemia, 15 (9), pp. 1485-1487van Dongen, J.J., Seriu, T., Panzer-Grumayer, E.R., Biondi, A., Pongers-Willemse, M.J., Corral, L., Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia: a prospective study of the International BFM Study Group (1998) Lancet, 352 (9142), pp. 1731-1738Cavé, H., van der Werff ten Bosch, J., Suciu, S., Guidal, C., Waterkeyn, C., Otten, J., Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer Childhood Leukemia Cooperative Group (1998) N Engl J Med, 339 (9), pp. 591-598Dworzak, M.N., Fröschl, G., Printz, D., Mann, G., Pötschger, U., Mühlegger, N., Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia (2002) Blood, 99 (6), pp. 1952-1958Cazzaniga, G., Biondi, A., Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology (2005) Haematologica, 90 (3), pp. 382-390Schrappe, M., Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patient (2012) Hematol Am Soc Hematol Educ Program, 2012, pp. 137-142Kroft, S.H., Role of flow cytometry in pediatric hematopathology (2004) Am J Clin Pathol, 122, pp. S19-S32Szczepański, T., Beishuizen, A., Pongers-Willemse, M.J., Hählen, K., Van Wering, E.R., Wijkhuijs, A.J., Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease (1999) Leukemia, 13 (2), pp. 196-205Scrideli, C.A., Assumpção, J.G., Ganazza, M.A., Araújo, M., Toledo, S.R., Lee, M.L., A simplified Minimal Residual Disease (MDR) PCR method at early treatment points stratifies children with acute lymphoblastic leukemia into good and poor outcome groups (2009) Haematologica, 94 (6), pp. 781-789Meshinchi, S., Woods, W.G., Stirewalt, D.L., Sweetser, D.A., Buckley, J.D., Tjoa, T.K., Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia (2001) Blood, 97 (1), pp. 89-94van Dongen, J.J., Langerak, A.W., Brüggemann, M., Evans, P.A., Hummel, M., Lavender, F.L., Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 (2003) Leukemia, 17 (12), pp. 2257-2317Pongers-Willemse, M.J., Seriu, T., Stolz, F., d'Aniello, E., Gameiro, P., Pisa, P., Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia (1999) Leukemia, 13 (1), pp. 110-118Assumpção, J.G., Ganazza, M.A., de Araújo, M., Silva, A.S., Scrideli, C.A., Brandalise, S.R., Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy (2010) Pediatr Blood Cancer, 55 (7), pp. 1278-1286Verhagen, O.J., Willemse, M.J., Breunis, W.B., Wijkhuijs, A.J., Jacobs, D.C., Joosten, S.A., Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia (2000) Leukemia, 14 (8), pp. 1426-1435van der Velden, V.H., Willemse, M.J., van der Schoot, C.E., Hahlen, K., van Wering, E.R., van Dongen, J.J., Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR (2002) Leukemia, 16 (5), pp. 928-936van der Velden, V.H., Wijkhuijs, J.M., Jacobs, D.C., van Wering, E.R., van Dongen, J.J., T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis (2002) Leukemia, 16 (7), pp. 1372-1380Szczepanski, T., van der Velden, V.H., Hoogeveen, P.G., de Brie, M., Jacobs, D.C., van Wering, E.R., V delta 2-J alpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but are rare in normal lymphoid cells (2004) Blood, 103 (10), pp. 3788-3804Chen, X., Pan, Q., Stow, P., Behm, F.G., Goorha, R., Pui, C.-H., Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay (2001) Leukemia, 15 (1), pp. 166-170van der Velden, V.H., Panzer-Grümayer, E.R., Cazzaniga, G., Flohr, T., Sutton, R., Schrauder, A., Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting (2007) Leukemia, 21 (4), pp. 706-713(2009) Protocolo de tratamento da leucemia linfoide aguda em crianças, , Sociedade Brasileira de Oncologia Pediátricavan der Velden, V.H., Szczepanski, T., Wijkhuijs, J.M., Hart, P.G., Hoogeveen, P.G., Hop, W.C., Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease (2003) Leukemia, 17 (9), pp. 1834-1844Flohr, T., Schurauder, A., Cazzaniga, G., Panzer-Grümayer, R., van der Velden, V., Fischer, S., Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia (2008) Leukemia, 22 (4), pp. 771-782Thorn, I., Forestier, E., Thuresson, B., Wasslavik, C., Malec, M., Li, A., Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006 (2009) Eur J Haematol, 84 (2), pp. 117-127Ganazza, M.A., Assumpção, J.G., de Araújo, M., Scrideli, C.A., Tone, L.G., Brandalise, S.R., TCRG gene rearrangement patterns in Brazilian children with ALL: an update (2009) Leuk Res, 33 (12), pp. 228-229Mansur, M.B., Emerenciano, M., Brewer, L., Sant'Ana, M., Mendonça, N., Thuler, L.C., SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome (2009) Leuk Lymphoma, 50 (8), pp. 1318-1325Van der Velden, V.H., Willemse, M.J., Van der Schoot, C.E., Hählen, K., Van Wering, E.R., Van Dongen, J., Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR (2002) Leukemia, 16 (5), pp. 928-936Salari, F., Shahjahani, M., Shahrabi, S., Saki, N., Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches (2014) Med Oncol, 31 (11), p. 266Conter, V., Bartram, C.R., Valsecchi, M.G., Schrauder, A., Panzer-Grumayer, R., Möricke, A., Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study (2010) Blood, 115 (16), pp. 3206-3214Karsa, M., Dalla Pozza, L., Venn, N.C., Law, T., Shi, R., Giles, J.E., Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease (2013) PLoS One, 8 (10), p. e76455Paganin, M., Fabbri, G., Conter, V., Barisone, E., Polato, K., Cazzaniga, G., Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia (2014) J Clin Oncol, 32 (31), pp. 3553-3558